Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion

被引：0
|
作者：
Tamiya, M. [1 ]
Tamiya, A. [2 ]
Asami, K. [2 ]
Okishio, K. [3 ]
Kawagchi, T. [2 ]
Suzuki, H. [1 ]
Okamoto, N. [1 ]
Kawase, I. [1 ]
Atagi, S. [3 ]
Hirashima, T. [1 ]
机构：
[1] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr, Habikino, Japan
[2] Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[3] Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3492
引用
收藏
页码：S826 / S826
页数：1
相关论文
共 50 条
  • [41] Randomized phase II study comparing cisplatin plus pemetrexed plus bevacizumab with carboplatin plus paclitaxel plus bevacizumab in treatment-naive advanced non-squamous non-small cell lung cancer (CLEAR study)
    Koyama, R.
    Udagawa, H.
    Sugiyama, E.
    Komuta, K.
    Mori, M.
    Yokoyama, T.
    Sasaki, T.
    Saito, H.
    Ishida, H.
    Nakagawa, H.
    Sekine, A.
    Tamura, A.
    Shingyoji, M.
    Mizuno, K.
    Nakamura, A.
    Kinoshita, A.
    Yamanaka, T.
    Goto, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] NEJ016: Phase II study of carboplatin and weekly paclitaxel plus bevacizumab followed by bevacizumab for highly selected elderly non-squamous non-small cell lung cancer patients
    Harada, T.
    Miura, S.
    Maemondo, M.
    Iwashima, A.
    Sugawara, S.
    Kobayashi, K.
    Inoue, A.
    Nakagawa, T.
    Takiguchi, Y.
    Watanabe, H.
    Seike, M.
    Ishida, T.
    Terada, M.
    Gemma, A.
    Yoshizawa, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S617 - S617
  • [43] Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer
    Yuichi Takiguchi
    Shunichiro Iwasawa
    Koichi Minato
    Yosuke Miura
    Akihiko Gemma
    Rintaro Noro
    Kozo Yoshimori
    Masato Shingyoji
    Mitsunori Hino
    Masahiro Ando
    Hiroaki Okamoto
    International Journal of Clinical Oncology, 2015, 20 : 659 - 667
  • [44] An open-label, phase II trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel), carboplatin, and bevacizumab in first-line patients with advanced non-squamous non-small cell lung cancer (NSCLC)
    Reynolds, C.
    Barrera, D.
    Vu, D. Q.
    Jotte, R.
    Spira, A. I.
    Weissman, C. H.
    Boehm, K. A.
    Ilegbodu, D.
    Pritchard, S.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)
    Noro, R.
    Kobayashi, K.
    Usuki, J.
    Hosomi, Y.
    Nishitsuji, M.
    Okamoto, H.
    Ando, M.
    Hino, M.
    Hagiwara, K.
    Miyanaga, A.
    Seike, M.
    Kubota, K.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non-Small Cell Lung Cancer
    Parody-Rua, Elizabeth
    Augusto Guevara-Cuellar, Cesar
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 93 - 98
  • [47] RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH CISPLATIN PLUS PEMETREXED AS FIRST LINE THERAPY FOR ADVANCED NON-SMALL CELL NON-SQUAMOUS LUNG CANCER
    Inui, Toshiya
    Yokoyama, Takuma
    Takata, Saori
    Hirata, Aya
    Nishizawa, Tomotaka
    Hirukawa, Ichiro
    Wada, Hiroo
    Ishii, Haruyuki
    Takizawa, Hajime
    Goto, Hajime
    RESPIROLOGY, 2013, 18 : 149 - 149
  • [48] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
  • [49] Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study
    Qi Wei
    Taibing Deng
    Junhua Wu
    Hao Zeng
    Chang Qi
    Sihan Tan
    Yuanyuan Zhang
    Qin Huang
    Xin Pu
    Weiguo Xu
    Weimin Li
    Panwen Tian
    Yalun Li
    BMC Cancer, 24
  • [50] THE COMBINATION CHEMOTHERAPY OF BEVACIZUMAB PLUS GEMCITABINE AND CARBOPLATIN IN PATIENTS WITH ADVANCED SQUAMOUS NON-SMALL CELL LUNG CANCER
    Kim, Taekyu
    Ahn, Young Mi
    Nam, Seung-hyun
    Kim, Bong-seog
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
12345